Foundation Medicine is a molecular information company developing clinical diagnostic tests that facilitate personalized cancer therapies. It provides clinical assays, FoundationOne for solid tumors and FoundationOne Heme for hematologic malignancies and sarcomas that provide a comprehensive genomic profile to identify the molecular alterations in a patient's cancer and match them with relevant targeted therapies and clinical trials. The company also offers a molecular information platform that aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers, and drug developers to help advance the science of molecular medicine in cancer.